La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « PascalFr.i » - entrée « Locus niger »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Locus coeruleus < Locus niger < Logement habitation  Facettes :

List of bibliographic references indexed by Locus niger

Number of relevant bibliographic references: 55.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000B98 (2014) YIMING XIAO [Canada] ; Pierre Jannin [France] ; Tiziano D'Albis [France] ; Nicolas Guizard [Canada] ; Claire Haegelen [France] ; Florent Lalys [France] ; Marc Verin [France] ; D. Louis Collins [Canada]Investigation of Morphometric Variability of Subthalamic Nucleus, Red Nucleus, and Substantia Nigra in Advanced Parkinson's Disease Patients Using Automatic Segmentation and PCA-Based Analysis
001005 (2013) Alexander C. Sutton [États-Unis] ; Wilson Yu [États-Unis] ; Megan E. Calos [États-Unis] ; Lauren E. Mueller [États-Unis] ; Matthew Berk [États-Unis] ; Jenny Shim [États-Unis] ; Eric S. Molho [États-Unis] ; Jonathan M. Brotchie [Canada] ; Peter L. Carlen [Canada] ; Damian S. Shin [États-Unis]Elevated potassium provides an ionic mechanism for deep brain stimulation in the hemiparkinsonian rat
001044 (2013) Mahan Alavi [Canada] ; Jonathan O. Dostrovsky [Canada] ; Mojgan Hodaie [Canada] ; Andres M. Lozano [Canada] ; William D. Hutchison [Canada]Spatial extent of beta oscillatory activity in and between the subthalamic nucleus and substantia nigra pars reticulata of Parkinson's disease patients
001047 (2013) Raymond T. Bartus [États-Unis] ; Tiffany L. Baumann [États-Unis] ; Joao Siffert [États-Unis] ; Christopher D. Herzog [États-Unis] ; Ron Alterman [États-Unis] ; Nicholas Boulis [États-Unis] ; Dennis A. Turner [États-Unis] ; Mark Stacy [États-Unis] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; C. Warren Olanow [États-Unis]Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients
001405 (2012) Aron S. Buchman [États-Unis] ; Sukriti Nag [États-Unis] ; Joshua M. Shulman [États-Unis] ; Andrew S. P. Lim [Canada] ; Veronique G. J. M. Vanderhorst [États-Unis] ; Sue E. Leurgans [États-Unis] ; Julie A. Schneider [États-Unis] ; David A. Bennett [États-Unis]Locus coeruleus neuron density and parkinsonism in older adults without Parkinson's disease
001955 (2011) Tyler M. Rolheiser [Canada] ; Heather G. Fulton [Canada] ; Kimberley P. Good [Canada] ; John D. Fisk [Canada] ; J. Roger Mckelvey [Canada] ; Christophe Scherfler [Autriche] ; Naeem M. Khan [Canada] ; Ronald A. Leslie [Canada] ; Harold A. Robertson [Canada]Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's disease
001C79 (2010) Martin Parent [Canada] ; André Parent [Canada]Substantia Nigra and Parkinson's Disease: A Brief History of Their Long and Intimate Relationship
001D08 (2010) Myriam Lafreniere-Roula [Canada] ; Elaine Kim [Canada] ; William D. Hutchison [Canada] ; Andres M. Lozano [Canada] ; Mojgan Hodaie [Canada] ; Jonathan O. Dostrovsky [Canada]High-frequency microstimulation in human globus pallidus and substantia nigra
001F18 (2009) I. A. Prescott [Canada] ; J. O. Dostrovsky [Canada] ; E. Moro [Canada] ; M. Hodaie [Canada] ; A. M. Lozano [Canada] ; W. D. Hutchison [Canada]Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients
002092 (2009) Emily N. Mangano [Canada] ; Shawn Hayley [Canada]Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: Neuroimmune sensitization of neurodegeneration
002392 (2008) Y.-Y. Lai [États-Unis] ; K.-C. Hsieh [États-Unis] ; D. Nguyen [États-Unis] ; J. Peever [Canada] ; J. M. Siegel [États-Unis]NEUROTOXIC LESIONS AT THE VENTRAL MESOPONTINE JUNCTION CHANGE SLEEP TIME AND MUSCLE ACTIVITY DURING SLEEP : AN ANIMAL MODEL OF MOTOR DISORDERS IN SLEEP
002553 (2007) Rohita Sharma [Canada] ; Catherine R. Mcmillan [Canada] ; Lennard P. Niles [Canada]Neural stem cell transplantation and melatonin treatment in a 6‐hydroxydopamine model of Parkinson’s disease
002635 (2007) Matthew J. Lavoie [États-Unis] ; Giuseppe P. Cortese [États-Unis] ; Beth L. Ostaszewski [États-Unis] ; Michael G. Schlossmacher [Canada]The effects of oxidative stress on parkin and other E3 ligases
002638 (2007) Mélanie Bourque [Canada] ; BIN LIU [États-Unis] ; Dean E. Dluzen [États-Unis] ; Therese Di Paolo [Canada]Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity
002639 (2007) Brian N. Mathur [États-Unis] ; M. Diana Neely [États-Unis] ; Melanie Dyllick-Brenzinger [Canada] ; Anurag Tandon [Canada] ; Ariel Y. Deutch [États-Unis]Systemic administration of a proteasome inhibitor does not cause nigrostriatal dopamine degeneration
002687 (2007) L. Borgal [Canada] ; M. Hong [Canada] ; D. Sadi [Canada] ; I. Mendez [Canada]Differential effects of glial cell line-derived neurotrophic factor on A9 and A10 dopamine neuron survival in vitro
002899 (2006) Martine Saint-Pierre [Canada] ; Marie-Eve Tremblay [Canada] ; Attila Sik [Canada] ; Robert E. Gross [États-Unis] ; Francesca Cicchetti [Canada]Temporal effects of paraquat/maneb on microglial activation and dopamine neuronal loss in older rats
002903 (2006) Pepijn Van Den Munckhof [Canada] ; Francois Gilbert [Canada] ; Michel Chamberland [Canada] ; Daniel Levesque [Canada] ; Jacques Drouin [Canada]Striatal neuroadaptation and rescue of locomotor deficit by L-dopa in aphakia mice, a model of parkinson's disease
002905 (2006) J. Miklossy [Canada] ; D. D. Doudet [Canada] ; C. Schwab [Canada] ; S. Yu [Canada] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada]Role of ICAM-1 in persisting inflammation in parkinson disease and MPTP monkeys
002B16 (2005) Sarah A. Baker [États-Unis] ; Lianne E. Stanford [Canada] ; Richard E. Brown [Canada] ; Theo Hagg [États-Unis]Maturation but not survival of dopaminergic nigrostriatal neurons is affected in developing and aging BDNF-deficient mice
002B43 (2005) Deniz Kirik [Suède] ; Anders Björklund [Suède] ; Ivar Mendez [Canada] ; Rosario Sanchez-Pernaute [États-Unis] ; Oliver Cooper [États-Unis] ; Angel Vinuela [États-Unis] ; Daniela Ferrari [États-Unis] ; Lars Björklund [États-Unis] ; Alain Dagher [Canada] ; Ole Isacson [États-Unis]Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Commentary

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Locus niger" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Locus niger" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Locus niger
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022